The family of cryopyrin-associated periodic syndrome (CAPS) is linked with mutations in the NLRP3 gene, encoding a structurally crucial inflammasome protein, named cryopyrin, which directly controls the release of bioactive IL-1β [1, 72]. This evidence concerns the gene IL1B and cryopyrin-associated periodic syndrome.